Invoke Capital

Luminance Technologies Ltd., established in 2015 and headquartered in London, specializes in developing AI-powered software for legal document analysis. Its platform employs advanced machine learning techniques, such as natural language processing and deep neural networks, to assist businesses and legal teams in reviewing, understanding, and managing contracts and other legal documents. The software offers features like risk clause identification, data visualization, anomaly detection, and task allocation, enabling users to streamline workflows, enhance decision-making, and improve compliance. It caters to multinational organizations, governments, and legal professionals, supporting various industries and legal matters.

Featurespace is a leader in enterprise financial crime prevention, specializing in fraud detection and anti-money laundering solutions. The company has developed innovative technologies, including Adaptive Behavioral Analytics and Automated Deep Behavioral Networks, which are incorporated into its ARIC platform. This real-time machine learning software assesses risk and monitors customer data across more than 180 countries to identify fraudulent activities and suspicious behavior promptly. The ARIC Risk Hub utilizes advanced anomaly detection methods, allowing financial institutions to automatically recognize potential threats and respond to them effectively. Over 30 major global financial institutions, including well-known names such as HSBC and NatWest, leverage Featurespace’s solutions to safeguard their operations and enhance customer satisfaction while minimizing fraud-related costs.

Featurespace is a leader in enterprise financial crime prevention, specializing in fraud detection and anti-money laundering solutions. The company has developed innovative technologies, including Adaptive Behavioral Analytics and Automated Deep Behavioral Networks, which are incorporated into its ARIC platform. This real-time machine learning software assesses risk and monitors customer data across more than 180 countries to identify fraudulent activities and suspicious behavior promptly. The ARIC Risk Hub utilizes advanced anomaly detection methods, allowing financial institutions to automatically recognize potential threats and respond to them effectively. Over 30 major global financial institutions, including well-known names such as HSBC and NatWest, leverage Featurespace’s solutions to safeguard their operations and enhance customer satisfaction while minimizing fraud-related costs.

SOPHiA GENETICS is a healthcare technology company specializing in data-driven medicine. It offers the SOPHiA DDM™ Platform, a cloud-based SaaS solution that analyzes complex multimodal datasets from various diagnostic modalities to generate insights. With over 780 global clients, including hospitals, laboratories, and biopharma institutions across three continents, the company aims to make data-driven medicine the standard of care in healthcare and life sciences research.

Luminance Technologies Ltd., established in 2015 and headquartered in London, specializes in developing AI-powered software for legal document analysis. Its platform employs advanced machine learning techniques, such as natural language processing and deep neural networks, to assist businesses and legal teams in reviewing, understanding, and managing contracts and other legal documents. The software offers features like risk clause identification, data visualization, anomaly detection, and task allocation, enabling users to streamline workflows, enhance decision-making, and improve compliance. It caters to multinational organizations, governments, and legal professionals, supporting various industries and legal matters.

Darktrace Limited is a cybersecurity company that specializes in intelligence-led, behavioral cyber defense solutions. Founded in 2013 and headquartered in Cambridge, United Kingdom, the company employs self-learning artificial intelligence modeled on the human immune system to protect over 3,500 organizations from a wide range of cyber threats, including insider threats, industrial espionage, and malware. Darktrace's platform is designed for scalability and can be deployed as software, an appliance, or as a service. Key offerings include the Darktrace Cyber Intelligence Platform, which provides enterprise-wide security, and Darktrace Antigena, an autonomous response solution that neutralizes threats in real time. The company has a global presence with over 1,200 employees and 44 offices, serving clients in government, military, and private sectors. Darktrace also maintains a strategic partnership with Options Technology and generates significant revenue from the USA and Canada, along with operations in the UK, Europe, and other regions.

Neurence Limited, based in Cambridge, United Kingdom, develops self-learning artificial intelligence software solutions that enable devices to understand and react to their environments. Founded by a team of mathematicians and software engineers, Neurence has created a cloud-based platform that functions as a central repository for information. This platform allows devices to outsource processing tasks to Neurence’s intelligent cloud, enhancing their ability to perceive and respond to various situations. By leveraging advanced mathematical and computational algorithms, Neurence enables connected devices to access its extensive knowledge base, which continually evolves through machine learning. As devices share sensory data, Neurence learns from collective experiences, optimizing responses based on historical outcomes. This innovative approach results in devices that are lighter, faster, and more cost-effective to manufacture, while also improving their overall efficiency in real-world applications.

SOPHiA GENETICS is a healthcare technology company specializing in data-driven medicine. It offers the SOPHiA DDM™ Platform, a cloud-based SaaS solution that analyzes complex multimodal datasets from various diagnostic modalities to generate insights. With over 780 global clients, including hospitals, laboratories, and biopharma institutions across three continents, the company aims to make data-driven medicine the standard of care in healthcare and life sciences research.

Darktrace Limited is a cybersecurity company that specializes in intelligence-led, behavioral cyber defense solutions. Founded in 2013 and headquartered in Cambridge, United Kingdom, the company employs self-learning artificial intelligence modeled on the human immune system to protect over 3,500 organizations from a wide range of cyber threats, including insider threats, industrial espionage, and malware. Darktrace's platform is designed for scalability and can be deployed as software, an appliance, or as a service. Key offerings include the Darktrace Cyber Intelligence Platform, which provides enterprise-wide security, and Darktrace Antigena, an autonomous response solution that neutralizes threats in real time. The company has a global presence with over 1,200 employees and 44 offices, serving clients in government, military, and private sectors. Darktrace also maintains a strategic partnership with Options Technology and generates significant revenue from the USA and Canada, along with operations in the UK, Europe, and other regions.